AI-generated summary
The authors pooled nine randomized controlled trials of 346 patients with melasma to compare laser and laser compound therapy with other treatments. They report that laser therapy and laser compound therapy were associated with better patient global assessment and modified Melasma Area and Severity Index scores, and they describe the results as supporting improvement in melasma area and severity. The authors note that further high-quality clinical studies are needed to confirm the conclusion.
- Participants
- 346
- Studies included
- 9
- Who or what was studied
- Patients with melasma enrolled in nine randomized controlled trials
- Limits stated in the abstract
- The authors note that only four of the nine studies were assessed as low risk of bias and that further high-quality clinical studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Meta-analysis, Randomized controlled trial, Risk of bias. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.